S1P Therapeutics Inc.
Pharmaceutical company · Blacksburg, Virginia, United States
S1P Therapeutics Inc. is a pharmaceutical company headquartered in Blacksburg, Virginia, United States. Its earliest recorded incorporation is in 2019. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $301,373 in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $2 million sold in a notice filed in 2023.
S1P Therapeutics at a glance
What does S1P Therapeutics do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $301,373 in total (2023). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $2 million sold (2023).
Frequently asked questions about S1P Therapeutics
Where is S1P Therapeutics headquartered?
S1P Therapeutics Inc. is headquartered in Blacksburg, Virginia, United States.
What does S1P Therapeutics do?
S1P Therapeutics Inc. is a pharmaceutical company.
When was S1P Therapeutics founded?
The earliest incorporation on record for S1P Therapeutics Inc. is in 2019, according to public company registers.
Similar companies
- Landos Biopharma, Inc.Blacksburg, Virginia, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences